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Muscarinic reccptors of rcsistance vesscls (submucosal artcrioles, outside diametcr 50-75 J,Lm) from the guinea-pig small 
intestinc wcre invcstigatcd in vitro using a computcr-assisted vidcomicroscopy system (Diamtrak <~t ). The muscarinic receptor 
which mediates vasodilation of prccontractcd [U-46619 (300 nM) or (- )-noradrcnaline (1 0 J.L M)] artcriolcs was characterized 
with scveral muscarinic agonists and subtypc-sclectivc antagonists. Thc following agonists all produccd cquivalent maximum 
vasodilation (given in rank ordcr of potency): acctylcholinc = arccaidinc propargyl cstcr (APE) > oxotremorine = ( ± )-muscarinc 
= ( ± )-mcthacholinc > carbachol > 4-[[N-{4-chlorophenyl)carbamoyl]oxy]-2-hutynyltrimcthylammonium iodide (4-CI-McN-A-
343). 4-([N-(3-ChlorophcnyD-carbamoyl)oxy]-2-butynyltrimcthylammonium chloride (McN-A-343) and N-ethyl-guvacinc propargyl 
ester (NEN-APE) produccd minimal or no artcriolar vasodilation. Thc muscarinic antagonists pircnzcpinc, ( ± )-5,11-dihydro-11-
[[[2-[2-((dipropylamino)methyl}-1-pipcridinyl]ethyl]amino ]-carbonyi]-6H-pyrido(2,3-h)( 1 ,4)-benzodiazcpin-6-onc (AF-DX 384 ), 11-
[[ 4-[4-(dicthylamino)butyl]-1-piperidinyl]acetyl]-5, ll-dihydro-6H-pyrido(2.3-h)( 1,4 )-bcnzodiazepin-6-onc (AQ-RA 741 ), p-fluoro-
hexahydro-sila-difcnidol (p-F-HHSiD), 4-diphcnylacetoxy-N-methylpipcridine mcthiodidc (4-DAMP) and (R)- and (S)-
hexahydro-difcnidol [(R)-HHD, (S)-HHD] shifted thc muscarinc, mcthacholinc or carbachol dosc-rcsponsc curve to the right in a 
compctitive manner. Schildanalysis of the data yicldcd pA 2 valucs for pircnzcpinc (6.74/6.9), AF-DX 384 (6.72), AQ-RA 741 
(6.58), p-F-HHSiD (7.53j7.57), 4-DAMP (9.06), (R)-HHD (7.88/8.32) and (S)-HHD (5.52/5.88). Thus, it can he concluded that 
submucosal arteriolcs posscss only thc M 3 functional muscarinic reccptor, the activation of which causcs hlood vcsscl dilation. 
The prcparation dcscribcd is considcrcd to bc a valuahlc ncw bioassay for pharmacological invcstigations of drug actions at 
muscarinic reccptors in the periphcral vascular systcm. 
Muscarinic rcceptor subtypcs; Muscarinic rcceptor agonists (M 1-sclcctivc); Muscarinic receptor antagonists (M 3-selcctive); 
p-Fiuoro-hexahydro-sila-difenidol; Smooth musclc (arteriolar); Submucosal plcxus (guinea-pig); 
Stereoselcctivity (at muscarinic rcceptors); Vidcomicroscopy 
1. Introduction 
It is now generally accepted that three distinct mus-
carinic receptor subtypes can be distinguished by phar-
macological mcans {Eglen and Whiting, 1986; Mitchel-
son, 1988; Levine and Birdsall, 1989; Lazarcno et al., 
1990; Lambrecht et al., 1989; Waelbroeck et al., 1989, 
1990, 199Ia). These three subtypes, termed M 1, M 2 
and M 3 receptors, have also becn shown to correspond 
to the structurally distinct cloned muscarinic receptors 
ml, m2 and m3, respectively (Akiba et al., 1988; Bon-
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ner et al., 1987; Buckley et al., 1989; Dörje et al., 
1991b). M 1 receptors appcar tobe locatcd primarily on 
neuronal tissue, M 2 reccptors have been most often 
localized in cardiac tissue, smooth muscle and lower 
brain areas and M 3 rcceptors are found predominantly 
in exocrinc glands and smooth muscle {Eglen and 
Whiting, 1986; Mitchelson, 1988; Lambrecht et al., 
1989; Waelbroeck et al., 1990; Dörje et al., 1991a). 
There is a candidate M4 receptor, found in rat stria-
tum (Waelbroeck et al., 1 990). rabbit Jung (Lazareno et 
al., 1990) and NG108-l5 cells (Michel et al., 1989; 
Caulfield and Brown, 1991), which is considered to be 
the m4 gene product (Dörje et al., 199la; Brann et al., 
1988). 
Each of the three subtypes, M 1, M 2 and M 3, can be 
identified in vascular prcparations depending on thc 
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species, tissue and function examincd. In general, M 3 
receptors mediate EDRF-depcndent relaxation, M 1 re-
ccptors mediate venous contraction and M 2 or M .~ 
rcceptors appear to inhibit noradrcnaline overflow 
(Fernandcs et al., 1991; for a rcview, see Eglcn and 
Whiting, 1990). Reccntly, M _, receptors havc been im-
plicated in endothclial-dependent vascular relaxation 
in the rabbit car artery and in bovine coronary artery, 
mediating both endothelial-depcndent rclaxation as 
wcll as endothelial-indepcndent vascular contraction 
(Duckles and Garcia-Villalon, 1990; Brunn er et al., 
199la,b). 
Muscarinic receptors, whose activation produces va-
sodilation, havc also becn demonstratcd in resistancc 
vcssels of the gastrointestinal microcirculation, thc sub-
mucosal arterioles of guinea-pig ileum (Neild ct al., 
1990). These submucosal artcriolcs arc inncrvatcd by 
cholinergic enteric neurones and thesc ncuroncs rc-
leasc acctylcholinc to produce pronounccd vasodila-
tion. This vasodilation is presumably causcd by activa-
tion of M 3 rcceptors prescnt on thesc blood vessels 
although it is not yet known whcther muscarinic rccep-
tors reside on vascular smooth muscle directly or on 
thc vascular endothelium (Neild et al., 1990). 
The present expcrimcnts werc undcrtaken to pro-
vide a dctailed pharmacological characterization of the 
muscarinic rcceptor subtype which mediates thc 
cholinergic vasodilation in submucosal arterioles of 
guinca-pig ileum. The in vitro submucosal artcriolar 
preparation uscd (Neild ct al., 1990) allows the study of 
rcceptor-mediated vasodilation by means of a com-
putcr-assisted vidcomicroscopy system without the need 
to isolate individual segmcnts of thc vascular trec. 
2. Materials and methods 
Thc pharmacological experiments were pcrformed 
at two different institutcs [Portland (U.S.A.) and 
Frankfurt (F.R.G.)] using nearly identical hardware. 
For tcchnical rcasons thc experimental design used in 
Portland differed slightly from that in Frankfurt (see 
table 1). The data obtained in Portland are marked as 
'method P' whereas those from Frankfurt are listed 
undcr 'method F'. 
2. I. Tissue preparation 
Submucosal plexus preparations were obtained from 
the small intestine of guinea-pigs that had been killed 
by a blow on the head and exsanguinated. Preparations 
were dissected as described previously (Neild et al., 
1990). Briefly, the mucosa was stripped from segments 
(8-12 mm long, 5-7 mm wide) of the small intestine 
and thc submucosal plexus was pulled away from the 
underlying circular smooth muscle. Thc plcxus was 
TABLE 1 
Experimental conditions used in Portland and Frankfurt (mcthod P 
and f) to dctcrminc muscarinic effccts in guinea-pig ileum submu-
cosal artcrio1es. For further dctails, sec tcxt. 
Method P Methnd F 
Buffer: Physiological salinc Tyrode s()Jution 
(mM) (mM) 
Na Cl 12().(} 137.00 
KCI 5.0 2.68 
CaCJ 2 2.5 1.80 
MgCJ 2 1.2 1.05 
NaHCOJ 25.0 11.90 
NaHzP04 1.2 0.42 
D-Giucose 11.0 5.05 
Tempcraturc: 34-36°C 32-34°C 
Prcconstriction: U-46619 Noradrenaline 
(2R5-300 nM) (10 ~M) 
Muscarinic agonist: M uscarinc 1 carhachol Methacholinc 
pinncd onto transparent silicone rubber, mucosal sur-
face down, in the base of a small organ bath (0.3-0.5 
ml volumc). The prcparation consistcd of arteriolar 
trecs, thc outside diamcters of which ranged from 
50-75 p.m; tcnsion applied to the connective tissue 
sheath rcsulted in approximately optimum-lcngth con-
ditions in the vascular nctwork (Vanner et al., 1990). 
Physiological saline solution or Tyrode solution (for 
composition see table 1 ), gassed with 95% 0 2-5% 
C0 2, flowed continuously at 32-36°C at 8-10 mljmin. 
Preparations were cquilibrated for 45-60 min prior to 
initiation of pharmacological experiments. 
2.2. Monitaring of arteriolar diameter 
The outside diameter of submucosal arterioles was 
monitorcd with the Diamtrak :~ system as dcscribcd 
previously (Neild, 1989; Neild et al., 1990). This system 
uscs an lmaging Tcchnology PCVisionPius frame-
grabber board (Woburn, MA, U.S.A.) in an AT-com-
patible computer to digitize television images of out-
side edges of the arteriole and converts this result to 
an analog signal which is displayed on a conventional 
strip chart recordcr. Resolution of the systcm was < 1 
~m; the sampling rate was 10-20 Hz. 
2.3. Agonist potencies 
To preconstrict the vessel, method P used the 
thromboxane receptor agonist U-46619 at a concentra-
tion of 285-300 nM, whereas in method F (- )-
noradrenalinc (10 p.M) was used. 8oth agonists pro-
duced 80-90% of the maximum contractile rcsponse. 
The noradrenalinc Solution was freshly prepared be-
forc each expcriment. No other precautions were taken 
to prevent oxidation of the catecholamine because of 
thc high concentration used and the short duration of 
each experiment (Neild and Kotecha, 1989). All mus-
carinic agonists werc applied to prcconstricted vcssels 
by superfusion for 2-4 min (per agonist concentration) 
with a 20-min washaut period between applications. In 
initial experiments, all agonists were applied in a non-
cumulative fashion with 4-6 concentrations of agonist 
applied to each vcsscl. In later experiments agonists 
wcre applied cumulatively because no significant dif-
fercnccs werc found bctween concentration-response 
curves obtained by either of these methods. The appar-
ent potcncy of a muscarinic agonist is expressed as its 
EC 511 value, i.c. the molar concentration inducing 50% 
of the individual maximal vasodilation. 
2.4. Antagonist affinities 
Affinitics for muscarinic antagonists werc obtained 
by constructing concentration-response curves for ago-
nists in the absence and then presencc of two to four 
increasing conccntrations of the antagonist. All antago-
nists wcre present for 12-15 min prior to agonist 
application. EC 511 values were used to construct Schild 
plots, and slopes were obtained by Ieast-squares fit. 
When slopes were not significantly different from unity, 
thc x-intercept (pA 2 value) was obtained by fitting the 
best linc with unit slope (Tallarida and Murray, 1986). 
2.5. Data analysis 
The data are presented as means ± S.E.M. Diffcr-
ences between mcan values were tcsted for statistical 
significance by using Student's t-test; P < 0.05 was ac-
cepted as being significant. 
2.6. Drugs 
The following drugs were used: acetylcholine chlo-
ridc, carbachol chloride, eserine hemisulfate, hexa-
methonium bromide, ( ± )-muscarine chloride, ox-
otremorine sesquifumarate, sodium nitroprusside and 
tetrodotoxin (all from Sigma, St. Louis, U.S.A.); (- )-
noradrenaline hydrochloride (Fiuka. Buchs, Switzer-
land); 9, 11-dideoxy-11 a ,9a-epoxy-methano-pros-
taglandin F2n (U-46619; Upjohn, Kalamazoo, U.S.A.); 
( ± )-methacholine chloride (EGA-Chemie, Steinheim, 
F .R.G. ); 4-[[N -0-chlorophenyl)-carbamoyl)oxy ]-2-
butynyltrimethylammonium chloride (McN-A-343; 
Serva, Hcidelberg, F.R.G.); 4-diphenylacetoxy-N-meth-
ylpipcridine methiodide (4-DAMP; Research Biochem-
ieals Inc., Natick, U.S.A.); pirenzepine dihydrochlo-
ride, ( ± )-5, 11-dihydro-11-[[[2-[2-((dipropylamino)-
methyl )-1-piperidinyl]ethyl]amino ]carbonyl ]-6H -pyrido-
(2,3-b )( 1,4 )-benzodiazepin-6-one methanesulfonatc 
(AF-DX 384), 11-[[4-[4-(diethylamino)butyl]-1-
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piperidinyl]acetyl)-5, ll-dihydro-6H-pyrido(2,3-b X I ,4 )-
benzodiazcpin-6-one (AQ-RA 741), all provided by 
Thomac (Biberach, F.R.G.); the (R)- and (S)- enan-
tiomcrs of hexahydro-difenidol ((R)-HHD and (S)-
HHD; Tacke et al., 1989), ( ± )-p-fluoro-hexahydro-
sila-difcnidol (p-F-HHSiD; Tacke et al., 1991 ), arecai-
dinc propargyl ester (APE; Mutschier and Hultzsch, 
1973), N-cthyl-guvacine propargyl ester (NEN-APE; 
Wolf-Pflugmann et al., 1989) and 4-[[N-(4-chloro-
phenyl)-carbamoyl]oxy]-2-butynyltrimethylammonium 
iodidc (4-CI-McN-A-343; Nelson ct al., 1976) were 
synthesizcd in our laboratorics. Thc other chemieals 
werc of reagent grade and were used as purchascd. 
3. Results 
3. /. Agonbits 
Figure 1 shows typical vasodilations produccd by 
muscarinic agonists applied in a cumulativc fashion to 
guinea-pig ileum submucosal arteriolar preparations. 
Maximum dilations produced by muscarine (fig. 1A) 
werc 84 ± R% (n = 43) and by methacholine 88 ± 6% 
(n = 4H) of the resting (non-constrictcd) outside diamc-
ter and this maximum response was not significantly 
different from the vasodilation produced by a supra-
maximal concentration of sodium nitroprusside (20 J.LM; 
vasodilation = 79 ± 6%, n = 14). All agonist effects 
were considercd to bc due to direct activation of mus-
carinic receptors on thc submucosal arterioles, and not 
to possiblc indirect activation of submucosal choliner-
gic neurones innervating the blood vessel, because re-
sponscs were not altered in the presence of hexa-
mcthonium (100 J.LM, n = 8) or tetrodotoxin (0.5-1 
J.LM, n = 12). 
Acetylcholine, muscarine, methacholine, carbachol, 
APE, oxotremorine and 4-CI-McN-A-343 dilated sub-
mucosal arterioles to the same maximum (fig. 2; data 
not shown for methacholine); EC50 valucs are shown in 
tablc 2. The acetylcholine-induccd vasodilation was 
significantly enhanced in the presence of the 
cholinesterasc inhibitor eserine ( 1 J.L M), which pro-
duced an approximatcly two-fold shift to the left in the 
concentration-vasodilation curve (fig. 2A). Higher con-
centrations of cserine (10 and 100 J.LM) had no further 
effect (n = 5). Vasodilations produced by the agonists 
werc maintained for the duration of agonist application 
and were reproducible in the same arteriolc for up to 5 
h during rcpeated applications at intervals of 20 min. 
McN-A-343 and NEN-APE were virtually ineffective in 
producing arteriolar vasodilation; concentrations as 
high as 100 J.L M produced less than 10% of the vasodi-
lation evoked by application of the other agonists (figs. 
lC and 2). 
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Fig. 1. Chart recordings of outside diameter of guinea-pig ileum submucosal arterioles preconstricted by 300 nM U-46619 during cumulative 
addition of muscarinic agonists to the superfusiun solution. Vasodilations in responsc to muscarine (A), APE (B), McN-A-343 (C) and 
4-Cl-McN-A-343 (0) are illustrated. Results in A through D obtained from different arterioles (method P). 
TABLE 2 
Puteneies of agonists at muscarinic receptors in guinea-pig ileum submucosal arterioles and longitudinal smuoth muscle. The data are presented 
as means ± S.E.M., the numbers of experiments are given in parentheses. i.a.- intrinsic activity. 
Agonist 
Acetylcholine 
Muscarine 
Methacholine 
APE 
NEN-APE 
Carbachol 
Oxotremorine 
4-CI-McN-A-343 
McN-A-343 
Guinea-pig ilcum submucosal arteriole EC50 (nM) 
Method P Method F 
35 ± 4 (16) 
170± 23 (34) 
40± 9 (13) 
450 ± 26 (29) 
185 ± 20 (6) 
4 900 ± 210 (9) 
> 100000 (9) 
190± 
42± 
> 100000 
16 (27) 
8 (7) 
(5) 
18000±5000 (6) 
> 100000 (5) 
Guinea-pig ileum longitudinal 
smooth muscle EC50 (nM) 
62 a 
250 h 
62 c 
17"' 
inactive, pA 2 = 6. I c: 
100" 
25 h 
4000 h 
10000, i.a. = 0.5 h 
a Data from Mutschier et al. (1983). b Data from Jokisch-Mehrling et al. (1989). c tarnbrecht et al., unpublished data . ..t Data from Moser et al. 
(1989). c Data from Eltze et al. (1991), rat ileum. 
TABLE 3 
Affinity constants (pA 2 values) and slopes of Schild plots for antagonists at muscarinic receptors in guinea-pig ileum submucosal arterioles and 
longitudinal smooth muscle. The data are presented as means ± S.E.M. of 6-19 experiments. 
Antagonist 
Pirenzepinc 
AF-DX 116 
HHSiD 
AF-DX 384 
AQ-RA 741 
p-F-HHSiD 
(R)-HHD 
(S)-HHD 
4-DAMP 
Guinea-pig ileum submucosal arteriole 
Method P 
7.57±0.03 
8.32±0.04 
5.88±0.04 
9.06±0.05 
Slope 
1.04 ±0.11 
1.04±0.08 
0.99 ±0.1 I 
0.95 ± 0.06 
Method F 
pA2 
6.74±0.06 
6.72±0.04 
6.58±0.05 
7.53 ±0.17 
7.H8±0.10 
5.52 ±0.09 c 
Guinea-pig ileum 
longitudinal 
smooth muscle 
Slope pAz 
0.95 ±0.13 6.9 b 
6.2 c 
8.0 h 
0.95 ±0.08 7.6 c 
1.09±0.10 6.6 c 
0.70±0.11 7.8 h 
0.98±0.18 H.4 ..t 
6.1 d 
9.3 r 
a Data from Neild et al. (1990). h Data from Lambrecht et al. (1989). c Data from Eberlein et al. (1989). d Data from Feitelet al. (1990). e Only 
two concentrations of (S)-HHD were investigated due to non-speciric effects of the antagonist at higher concentrations. The pA 2 value was 
therefore dctermined from the individual dosc ratios according to Tallarida et al. (1979). r Data from Dörje ct al. ( 1990). 
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Fig. 2. Action of muscarinic agonists to dilate guinea-pig ileum 
submucosal arterioles (method P). (A) Concentration-dilation curves 
for acetylcholine in the absencc (e) and presence (o) of the 
cholinesterase inhibitor eserine (l J,LM); n = 5-10 for each point. (8) 
Concentration-response curves for muscarinic agonists, APE (e), 
muscarine ( A ), oxotremorinc ( • ), carbachol (0). 4-CI-McN-A-343 
( •) and McN-A-343 ( o ); n - 9-24 for each point. All points are 
means ± S.E.M. Some crror bars were within the width of thc sym-
bols. 
3. 2. Antagonists 
The antagonists investigated all shifted the agonist 
concentration-vasodilation curves parallel to higher 
concentrations without any appreciable changes of pre-
Muscarina concentration (JlM) 
Muscarina concentration (J.LM) 
Fig. 3. Antagonism of muscarinic vasodilation by p-F-HHSiD (A) and 
(R)-HHD (8). Each graph shows data obtained from a single arteri-
ole (one typical experiment), preconstricted with 300 nM U-46619 
(method P). 
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Fig. 4. Schild plots obtained for muscarinic antagonists at guinea-pig 
ilcum submucosal arterioles preconstrictcd with 300 nM U-466 19 
using muscarine as agonist (method P). Log (dose ratio- l) is plotted 
as a function of log [(R)-HHD] (A). log [(S)-HHD] (8), log lp-F-
HHSiD] (C) or log [4-DAMP] (0). Lines are hest fit linear rt!gression 
lincs, using Ieast-squares fits. 
constriction or reduction of thc maximum response. 
This is illustrated for p-F-HHSiD and (R)-HHD in fig. 
3. The effects of 4-DAMP, (R)-HHD and p-F-HHSiD 
were readily reversible within 20-30 min of washout 
even at the highcst concentrations used, while those of 
(S)-HHD were slowly and, at the higher conccntra-
tions, only partially reversible (method P). Arunlak-
shana-Schild plots werc linear and slopes were not 
significantly different from unity, except in thc case of 
p-F-HHSiD (method F: slope = 0.7) and (S)-HHD 
(method P; using 10, 30, 100 and 300 1-'M to construct 
the Schild plot). However, when the highest antagonist 
concentration (300 ~J.M) was omitted from the analysis, 
the slope was not significantly different from unity 
(table 3). Therefore, it was assumed that this very high 
concentration of (S)-HHD produccd additional, non-
specific effects on submucosal arterioles. With mcthod 
F is was not possible to construct Schild plots for 
(S)-HHD bccause of similar nonspecific effects aceur-
ring at concentrations higher than 10 J.L M, which led to 
unstable declining preconstrictions. Thus, only two 
concentrations (3 and 10 1-' M) were investigated and 
the pA 2 value was therefore detcrmined from the 
individual dose ratios (Tallarida et al., 1979). The (R)-
enantiomer of HHD displayed 250- to 500-fold higher 
affinity than its corresponding (S)-isomer. Schild plots 
for 4-DAMP, (R)-HHD, (S)-HHD and p-F-HHSiD are 
shown in fig. 4 (method P). Table 3 summarizes antag-
onist pA 2 values obtained from all experiments. 
4. Discussion 
Based on pA 2 values obtained with pirenzepine, ( ± )-11-[[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-
5H 
5, 11-dihydro-6H-pyrido(2,3-bX 1 ,4)-benzodiazcpin-6-one 
(AF-DX 116) and hexahydro-sila-difcnidol (HHSiD) 
(table 3; Neild et al., 1990), wc had previously sug-
gested that submucosal artcrioles of the guinea-pig 
ileum possess the functional M ~ muscarinic reccptor 
which mediates vasodilation. 
This study was dcsigncd to characterizc this mus-
carinic receptor further, using agonists and a larger 
nurober of subtype selective antagonists including one 
pair of enantiomcrs. The experiments werc carried out 
at two institutes; the most important differences be-
twcen thc methods used in Portland and Frankfurt 
(method P and F) wcrc thc use of (- )-noradrenaline 
instcad of U-46619 to preconstrict the vessels and 
methacholine instcad of muscarine or carbachol as 
muscarinic agonist for antagonist invcstigations. Fur-
thermore there were minor diffcrenccs in the concen-
tration of Ca2+ and K + in thc buffcrs ( 1.8 vs. 2.5 mM, 
2.68 vs. 5 mM, rcspectivcly; table I). However, both 
mcthods produccd the same agonist potencics and 
antagonist affinitics (tables 2 and 3). 
Thc results from the prcsent study provide convinc-
ing evidencc that a singlc type of muscarinic reccptor. 
the M 1 subtypc, mediates thc cholinergic vasodilation 
in these submucosal arterioles. 
The agonists uscd in the present experiments, with 
the cxception of McN-A-343 and NEN-APE, acted as 
\• pK1 Hum1n NB-OK 1 (U1) 
t 
. 
I AQ-RA 141 •e 
AF-OX 3U 
II T I 
• HHSiD 
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full agonists in producing artcriolar vasodilation. The 
rank order of potcncy was acetylcholine = APE > 
oxotremorinc = muscarine = methacholine > carbachol 
> 4-Cl-McN-A-343. This is the same agonist profile as 
observed in functional experiments with the guinea-pig 
ilcal longitudinal smooth musclc preparation (table 2), 
the functional muscarinic rcccptor of which has bcen 
characterized as the M~ subtype. McN-A-343 was inef-
fective in producing vasodilation in submucosal arteri-
oles. This is consistent with its incffectiveness in pro-
ducing endothelial-dependent relaxation in rabbit ear 
artcry or cndothelial-independent contraction in bovine 
coronary artcry (Duckles, 19B8). McN-A-343 has hecn 
proposcd to act as a sclcctivc M 1 agonist (Jokisch-
Mehrling et al., 1989) hut exhibitsvariable responscs at 
all muscarinic rcceptor subtypes, depending upon thc 
rcceptor rescrve of the preparation (Eglen and Whit-
ing, 1986). Thc M 2 and M 3 activity rcported varics 
from no agonistic action (Eglen ct al., 1987) up to a 
partial agonism (pD 2 = 4.8 and 5.0, i.a. = 0.5 at both 
M 2 and M3 receptors CJokisch-Mchrling et al., 1989)). 
The weak agonism at M 2 and M 3 receptors of McN-A-
343 might explain its very low activity at submucosal 
arterioles and may cxclude the M 1 subtype for mcdiat-
ing the vasodilation. NEN-APE also shows an intcrest-
ing activity profile at muscarinic receptors. At M 2 
rcceptors it acts as a potent partial agonist (rabbit vas 
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Fig. 5. Comparison of functional antagonist affinities (pA 1 values, tahle 3) nbtained for pirenzepine (Pz), AF·DX 116, IIHSiD, 4-DAMP, AF-DX 
384, AQ-RA 741, p-F-JIHSiD, as weil as (R)- and (S)-HHD, at guinca-pig ileum submucosal arterioles (this study and Neild et al., 1990) to their 
binding affinity (pKi values) determined in radioligand binding assays at M 1, M 2 • M~ and M 4 receptors (Waelbroeck ct al.. 1990, J99la,b and 
personal communication). 
defcrens: pD2 = 6.3, i.a. = 1.1 or rat left atrium: pD2 = 
6.6, i.a. = 0.8). At M 1 (rabbit vas deferens) and M 3 (rat 
ileum) rcceptors it behaves as a competitive antagonist 
(pA 2 = 5.8 and pA 2 = 6.1, respectively) (Eltze et al., 
199 1). These findings might explain its Iack of agonistic 
activity at muscarinic reccptors in submucosal arteri-
oles. 
All antagonists investigated acted as pure competi-
tive antagonists of the methacholine-, muscarinc· or 
carbachol-induced vasodilation. Morcover, since the 
slopes of Arunlakshana-Schild regression lines did not 
significantly differ from unity (with cxception of p-F-
HHSiD, mcthod F), the prcsencc of a mixture of 
functional subtypes appears to bc unlikcly. Tablc 3 
shows that there is a remarkable agrcemcnt in pA 2 
valucs for the antagonists studied in submucosal artcri-
oles and in guinea-pig ileum longitudinal smooth mus-
cle preparations. lt is also worth noting that these 
valucs arc very similar to those obtained for the cloned 
m3 muscarinic receptor (Dörje ct al., 1991 b; Buckley ct 
al., 1989; Wesset al.. 1990. Figure 5 shows a compari-
son of the pA 2 values determincd at submucosal artc-
rioles and thc corresponding binding affinities (pK i 
values) obtained in radioligand binding assays at M 1, 
M2 , M3 and M 4 reccptors (data from Waelbroeck et 
al., 1990, I99la,b, and personal communication). For 
receptor identity, the data points should not signifi-
cantly deviate from the theoretical equality line (y = x). 
The distance to this linc (given in fig. 5 as antilog of 
thc difference between pA 2 and pK 1 values) is a direct 
measure of receptor selectivity. The affinity of piren-
zepine (pA 2 = 6.74) for the muscarinic receptor in sub-
mucosal arterioles was 40-fold lower than that ob-
served at M 1 (human NB-OKl cells) receptors, thercby 
cxcluding the presence of functional M 1 receptors. The 
evident discrimination for AQ-RA 741 (63-fold lowcr 
than observed at M 2 and 40-fold lower than dcter-
mined at M 4 receptors), AF-DX 3H4 and HHSiD (63-
fold highcr than observed at M 2 receptors) furthcr-
more clearly excludes M 2 or M4 receptors from medi-
ating the vasodilation. A highly significant correlation 
was found for the M 3 (rat pancreas) preparation only. 
Calculation of the eudismic index for the two enan-
tiomers of HHD (method P: 2.44, method F: 2.36) and 
comparison of thesc values with data obtained in the 
same radioligand assay (M 1: 2.2, M 2: 1.2, M3: 2.2, M4: 
2.0) also exclude the M 2 subtype and favour the M ·' 
subtype for mediating the vasodilation. Thus, it can be 
concluded that the functional muscarinic receptor me-
diating vasodilation in guinea-pig ileum submucosal 
arterioles is of the M 3 subtype. 
Dcpending on spccies, tissue and function mea-
sured, each of the three subtypes, M 1, M 2 and M :\• 
have bcen identified on vascular smooth muscle. In 
general, M 1 receptors mediate venous contraction, M 2 
or M3 receptors appear to inhibit noradrenaline over-
59 
flow and direct EDRF-dcpendent relaxations are me-
diated in the majority of preparations by M ·' receptors 
(Fcrnandes et al., 1991; for a review, see Eglen and 
Whiting, 1990). Recent studies report M ~ receptor-
mediated relaxation of the feline middlc cerebral artery 
(Dauphin and Harnet, 1990) and of bovine coronary 
artcry (Brunner et al., 1991a). In addition, a study of 
muscarinic rclaxation in the rabbit ear artcry has shown 
pA 2 values for pirenzepinc (6.8), AF-DX I 16 (6.0) and 
HHSiD (8.2) (Duckles and Garcia-Villalon, 1990) simi-
lar to those determined in submucosal artcriolcs (this 
study). Therefore our results ohtained with muscarinic 
agonists and antagonists are in good agrecment with 
thcse carlicr findings. 
In conclusion, the present study investigated the 
muscarinic reccptors of resistance vessels in guinea-pig 
ileum by the use of computer-assisted videomicroscopy. 
The muscarinic reccptor which mediates vasodilation 
of the precontracted submucosal arterioles was charac-
terized by determining the potcncies of a scries of 
muscarinic agonists and the affinities of various selcc-
tive muscarinic antagonists. The results providc con-
vincing evidence that a single type of muscarinic recep-
tor, the M 3 subtype, mediates thc cholinergic vasodila-
tion in submucosal artcrioles of thc guinea-pig ileum. 
Thus. thc application of computer-assisted videomi-
croscopy for tracking thc diameter of small rcsistance 
vesscls (i.e. arterioles) is a useful new method for 
pharmacological investigations of drug actions at mus-
carinic receptors in thc periphcral vascular system. 
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